Literature DB >> 2527937

Surgical management of drooling in the neurologically damaged child.

T P O'Dwyer1, C Timon, M A Walsh.   

Abstract

Continuous drooling after infancy is rarely seen in normal children. Neurologically damaged children are more likely to continue to drool, and it may be so severe in some cases as to require surgical correction. Submandibular duct relocation is a procedure with minimal morbidity and excellent results. This procedure has been carried out on 16 children at the Eye and Ear Hospital and Temple Street Children's Hospital, Dublin, between the years 1982 to 1987. An overall improvement occurred in 13 cases with only one post-operative complication. Such surgery has transformed the lives of these children as well as being a great source of relief for the parents.

Entities:  

Mesh:

Year:  1989        PMID: 2527937     DOI: 10.1017/s0022215100109971

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  5 in total

1.  Submandibular Duct Re-routing for Drooling in Neurologically Impaired Children.

Authors:  Prem Sagar; K K Handa; Sheffali Gulati; Rajeev Kumar
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2015-12-12

2.  Persistent drooling: treatment by bilateral submandibular duct transposition and simultaneous sublingual gland excision.

Authors:  M Ethunandan; D W Macpherson
Journal:  Ann R Coll Surg Engl       Date:  1998-07       Impact factor: 1.891

3.  Deterioration of feeding behavior following surgical treatment of drooling.

Authors:  R D Stevenson; J H Allaire; P A Blasco
Journal:  Dysphagia       Date:  1994       Impact factor: 3.438

4.  Bilateral submandibular duct relocation by high-frequency radiosurgery.

Authors:  Gábor Katona; Zsuzsa Csákányi; Anikó Lorincz; Imre Gerlinger
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-02-05       Impact factor: 2.503

5.  The association of drooling and health-related quality of life in children with cerebral palsy.

Authors:  Shih-Chung Chang; Chin-Kai Lin; Li-Chen Tung; Nai-Yin Chang
Journal:  Neuropsychiatr Dis Treat       Date:  2012-12-11       Impact factor: 2.570

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.